SENSEX 77414.92 ▼ (0.25%)
BSE BANKEX 59542.38 ▲ (0.36%)

CITIPORT FINANCIAL SERVICES LT

BSE: 531235 22 Aug 2025
Financial Services
₹ 26.25
Citiport Financial Services Ltd. specializes in Non Banking Financial Company (NBFC) within the Financial Services sector.

CITIPORT FINANCIAL SERVICES LT - Share Price & Details

Market Cap
₹8.14
High /Low
30.8 / 18.9
Stock P/E
204.0
Book Value
₹9.87
Dividend Yield
0.0
ROCE
0.0
ROE
₹0.0
Face Value
10.0
PEG Ratio
NA
EVEBITDA
₹223.0
Debt
0.96
CMP / FCF
-163.0
Debt to equity
₹0.31
NP Ann
0.00
High price all time
38.4
Piotroski score
₹4.0
Graham Number
5.35
No. Eq. Shares
0.31
Net CF
₹-0.01
Net profit
0.04
Price to book value
2.66
Interest Coverage
₹NA
Low price all time
0.0
Industry PE
21.8
Reserves
₹-0.04
Free Cash Flow
₹-0.02

Price Chart


Volume Chart


Peer Comparison

Stock Total Income Net Profit Net Sales EPS Market Cap (in Cr) P/E
ISHWARSHAKTI HOLDINGS & TRADERNANANANA0
Shikhar Leasing and Trading Ltd.NANANANA0
CITIPORT FINANCIAL SERVICES LTNANANANA8.14204.0
MATHEW EASOW RESEARCH SECURITINANANANA7.9788.6
K.Z.LEASING & FINANCE LTD.NANANANA7.84

Peer Comparison Chart


About CITIPORT FINANCIAL SERVICES LT

Citiport Financial Services Ltd., with Security Code 531235, is a leading player in the Non Banking Financial Company (NBFC) industry, categorized under the Financial Services sector, offering Equity instruments.


Latest News

Nibe bags $1.2 million defence order from Elbit Systems for Naval Launcher Kits

(12 Aug 2025)
Nibe has announced that it has received a purchase order from Elbit Systems Land, a leading global Israel-based defence technology company,...
Read more →

GIFT Nifty hits toward positive start to equities on D-Street

(11 Aug 2025)
GIFT Nifty: GIFT Nifty August 2025 futures were currently trading 15 points (or 0.06%) higher, suggesting a possible green opening for the...
Read more →

Zydus Lifesciences gets USDFA approval for Prucalopride tablets

(11 Aug 2025)
Zydus Lifesciences has received final approval from the US Food and Drug Administration (USFDA) for Prucalopride tablets, 1 mg and 2 mg.
Read more →

Narbada Gems & Jewellery standalone net profit declines 8.98% in the June 2025 quarter

(10 Aug 2025)
Net profit of Narbada Gems & Jewellery declined 8.98% to Rs 2.33 crore in the quarter ended June 2025 as against Rs 2.56 crore during the...
Read more →

Vraj Iron & Steel consolidated net profit declines 51.16% in the June 2025 quarter

(10 Aug 2025)
Net profit of Vraj Iron & Steel declined 51.16% to Rs 7.59 crore in the quarter ended June 2025 as against Rs 15.54 crore during the...
Read more →

CitiPort Financial Services standalone net profit rises 700.00% in the June 2025 quarter

(09 Aug 2025)
Net profit of CitiPort Financial Services rose 700.00% to Rs 0.08 crore in the quarter ended June 2025 as against Rs 0.01 crore during the previous quarter...
Read more →

Company Updates